中文 | English
Return
Total: 50 , 1/5
Show Home Prev Next End page: GO
Author:(Shengnan GAO)

1.Cost-utility analysis of anlotinib combined with penpulimab in first-line treatment of unresectable hepatocellular carcinoma

Wenying YAN ; Na YANG ; Ranran ZHANG ; Xinyue TAO ; Shengnan GAO ; Guoqiang LIU

China Pharmacy 2026;37(3):344-349

2.Cost-utility analysis of amivantamab combined with lazertinib in the first-line treatment of EGFR-mutated advanced NSCLC

Ran LIU ; Shengnan GAO ; Yuxi ZHANG ; Ranran ZHANG ; Congxin LI ; Guoqiang LIU

China Pharmacy 2026;37(5):633-638

3.Pharmacoeconomic evaluation of culmerciclib combined with fulvestrant in the second-line treatment of HR+/HER2− locally advanced or metastatic breast cancer

Ran LIU ; Shengnan GAO ; Congxin LI ; Yuxi ZHANG ; Ranran ZHANG ; Yue WANG ; Ziyi LIU ; Guoqiang LIU

China Pharmacy 2026;37(8):1033-1038

4.Differences in cytokines expression between mild and severe infant cases infected with respiratory syncytial virus

Guangyu XUE ; Yuting HU ; Kexin ZONG ; Qin LUO ; Shengnan YANG ; Miao FENG ; Xiaoyu YI ; Zhiqiang XIA ; Chen GAO ; Haijun DU ; Ying LI ; Ying CHEN ; Feng HE ; Yajuan WANG ; Yingli QU ; Jin CAO ; Wenyan TIAN ; Qinqin SONG ; Hailan YAO ; Jun HAN

Chinese Journal of Experimental and Clinical Virology 2025;39(3):370-377

5.Cost-Effectiveness of Inclisilan Injection in Patients with Atherosclerotic Cardiovascular Disease

Bing FENG ; Ning GAO ; Shengnan GAO ; Mengna NIU ; Shan GUO ; Guoqiang LIU

Herald of Medicine 2025;44(3):466-472

6.Cost-effectiveness analysis of sacituzumab tirumotecan versus single-agent chemotherapy in second-line and later-line treatment for metastatic triple-negative breast cancer

Ranran ZHANG ; Yuxi ZHANG ; Shengnan GAO ; Bing FENG ; Ning GAO ; Guoqiang LIU

China Pharmacy 2025;36(16):2024-2029

7.Dexmedetomidine alleviates ferroptosis in rat cerebral ischemia/re-perfusion injury by inhibiting the Nrf2 pathway

Huanran YANG ; Shengnan WU ; Qin GAO

Chinese Journal of Clinical Pharmacology and Therapeutics 2025;30(7):921-928

8.Cost-Effectiveness Analysis of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis

Bing FENG ; Ning GAO ; Shengnan GAO ; Ranran ZHANG ; Yuxi ZHANG ; Guoqiang LIU

Herald of Medicine 2025;44(6):955-960

9.Effect of exercise intervention based on the transtheoretical model on sedentary behavior in elderly patients with stroke

Siqian LI ; Kongyan ZHANG ; Yanan LIU ; Shengnan GAO

Chinese Journal of Modern Nursing 2025;31(35):4816-4821

10.Effect of exercise intervention based on the transtheoretical model on sedentary behavior in elderly patients with stroke

Siqian LI ; Kongyan ZHANG ; Yanan LIU ; Shengnan GAO

Chinese Journal of Modern Nursing 2025;31(35):4816-4821

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 50 , 1/5 Show Home Prev Next End page: GO